Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CRYAB | P02511 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 4/20 | 0.79 |
| ▸ | FNTA | P49354 | 1/20 | 0.74 |
| ▸ | FNTB | P49356 | 1/20 | 0.74 |
| ▸ | CRYAA | P02489 | 1/20 | 0.71 |
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.61 |
| ▸ | HMGCR | P04035 | 1/20 | 0.61 |
| ▸ | PREP | P48147 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lanosterol SCHEMBL18688634 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL1242765 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL17428540 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL288881 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL11914239 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Euphol SCHEMBL541497 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL20225105 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL15977092 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL21348006 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 | |
| Lanosterol SCHEMBL244737 | 1.00 | MAPT (1.00) | MAPTUSP2ALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102905763-A | Lipids, lipid compositions, and methods of using them | NOVARTIS AG | 2013-01-30 | — | — | CN | claimed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-4522646-A2 | APOE LIPOPROTEIN SYSTEMS | Kisbee Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| WO-2023220387-A2 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20200276211-A1 | COMPOUNDS FOR TREATING NEAR VISION DISORDERS | VIEWPOINT THERAPEUTICS INC (US) | 2020-09-03 | — | — | US | disclosed |
| US-20120289487-A1 | Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents | AMAZÔNIA FITOMEDICAMENTOS LTDA (BR) | 2012-11-15 | — | — | US | disclosed |
| CN-102711750-A | Pharmaceutical use of polycyclic compounds as anti-AIDS agents | AMAZONIA FITOMEDICAMENTOS LTDA | 2012-10-03 | — | — | CN | disclosed |
| WO-2011086424-A1 | PHARMACEUTICAL USE OF MULTICYCLIC COMPOUNDS MIXTURES AS CONCOMITANT ANTI-CANCER, ANTI-INFLAMMATORY AND ANTI-PAIN AGENTS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011086423-A1 | PHARMACEUTICAL USE OF MULTICYCLIC COMPOUNDS AS ANTI-AIDS AGENTS | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-07-21 | — | — | WO | disclosed |
| CN-102112133-A | Pharmaceutical uses of lanosta-8, 24-dien-3-ols | AMAZONIA FITOMEDICAMENTOS LTDA | 2011-06-29 | — | — | CN | disclosed |
| US-20110136773-A1 | Pharmaceutical Uses of Lanosta-8,24-dien-3-ols | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2011-06-09 | — | — | US | disclosed |
| CN-1863558-B | Polyarginine-modified liposomes having nuclear transfer ability | JAPAN SCIENCE & TECH AGENCY | 2010-12-29 | — | — | CN | disclosed |
| WO-2010015875-A1 | PROCESS FOR THE PREPARATION OF LANOSTA-8-ENE COMPOU | AMAZONIA FITOMEDICAMENTOS LTDA (BR) | 2010-02-11 | — | — | WO | disclosed |
| CN-101522876-A | Wheat-germ oil concentrate, a method for the production thereof, a method for producing wheat-germ oil and a medicinal and prophylactic composition based thereon and used for treating sexual dysfuncti | OTKRYTOE AKTSIONERNOE OBSCHEST (RU) | 2009-09-02 | — | — | CN | disclosed |
| CN-1863558-A | Polyarginine-modified liposomes having nuclear transfer ability | JAPAN SCIENCE & TECH AGENCY (JP) | 2006-11-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200276211-A1 | COMPOUNDS FOR TREATING NEAR VISION DISORDERS | CRYAB, PDE6C, CRYAA | MAPT 510/4885USP2 2084/4885ALDH1A1 1412/4885 |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | MAPT 1272/4885USP2 2046/4885ALDH1A1 3260/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885USP2 3358/4885ALDH1A1 3285/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885USP2 3112/4885ALDH1A1 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.